Natriuretic Peptides in Gastrointestinal Cancer: Biomarkers and Potential Therapeutic Targets

Area of Science:

• Endocrinology
• Oncology
• Gastroenterology

Background:

• Gastrointestinal (GI) cancers represent a significant global health burden.
• Conventional GI cancer therapies often exhibit limited efficacy and undesirable side effects.
• Natriuretic peptides (NPs), known for cardiovascular regulation, are emerging as potential therapeutic agents in oncology.

Purpose of the Study:

• To review current literature on the role of natriuretic peptides in GI cancers.
• To assess the pathways involved in NP-mediated GI cancer progression.
• To evaluate the potential of NPs in the prevention and treatment of GI cancers.

Main Methods:

• Literature review of recent studies on natriuretic peptides and GI cancers.
• Analysis of NP mechanisms, including effects on DNA synthesis and apoptosis.
• Synthesis of findings regarding NP roles in various tumor types.

Main Results:

• Natriuretic peptides demonstrate anti-proliferative and pro-apoptotic effects in various cancer types, including those of the GI tract.
• NPs exert anti-tumor effects by inhibiting DNA synthesis.
• The specific roles and pathways of NPs in GI cancer progression are diverse and require further elucidation.

Conclusions:

• Natriuretic peptides hold promise as a novel therapeutic strategy for GI cancers.
• Understanding NP pathways is crucial for developing effective prevention and treatment approaches.
• Further investigation into NPs' anti-cancer mechanisms in GI malignancies is warranted.